Weaver Capital Management LLC Has $825,000 Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Weaver Capital Management LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,747 shares of the company’s stock after purchasing an additional 133 shares during the period. Weaver Capital Management LLC’s holdings in HCA Healthcare were worth $825,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of HCA. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare during the third quarter worth $39,000. Canoe Financial LP acquired a new position in shares of HCA Healthcare during the third quarter worth $41,000. Capital Performance Advisors LLP acquired a new position in HCA Healthcare in the third quarter valued at $41,000. Northwest Investment Counselors LLC acquired a new position in HCA Healthcare in the third quarter valued at $44,000. Finally, Pinnacle Bancorp Inc. lifted its holdings in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $335.31 on Wednesday. The stock has a market cap of $84.93 billion, a PE ratio of 15.26, a PEG ratio of 1.13 and a beta of 1.64. The company’s fifty day moving average is $313.52 and its 200 day moving average is $353.59. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the firm posted $5.90 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.89 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. HCA Healthcare’s payout ratio is presently 12.02%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. TD Cowen decreased their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Truist Financial dropped their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.